Send to a Friend Font Size: Increase Decrease

GSK and SMMT Related Headlines

Jan 12, 2026 06:15AM Summit Therapeutics partners with GSK for cancer drug combination trial
Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

GSK and SMMT Related Press Releases

Jan 12, 2026 06:15AM Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)

GSK and SMMT Related SEC Filings